HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Uganda: First vaccination for GMZ2 malaria vaccine trial

Today, the EDCTP-funded GMZ2 consortium starts volunteer enrolment for the phase IIb clinical trial of the candidate malaria vaccine GMZ2 in Uganda. This is the third trial site to initiate volunteer recruitment for this multi-country study. Vaccination is already underway at trial sites in Gabon (November 2010) and Burkina Faso (April 2011). The Uganda site is in the peri-urban area of Iganga/Mayuge, at the Iganga Hospital. Akin to most areas in Uganda, malaria is one of the major health problems in this district. A team from Makerere University (Kampala) is conducting the trial.

9 May 2011

World's first urine-based tuberculosis diagnostics tool

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostics systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, in a new video today unveiled the world's first urine-based tuberculosis diagnostics tool.

9 May 2011

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of immune responses induced by VGX-3100, its investigational DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus.

9 May 2011

Study provides information about hematuria in microscopic urinalysis and urinary tract cancer

Hematuria or blood in the urine may trigger a battery of tests for urinary tract cancer that are invasive and can unnecessarily expose patients to radiation, yet the procedures contribute little to the diagnosis, according to a study by Kaiser Permanente Southern California's Department of Research & Evaluation published in the May issue of the Journal of Urology.

7 May 2011

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the prestigious journal Current Opinion in Immunology has published an article in its current issue entitled, "Electroporation Delivery of DNA Vaccines: Prospects for Success."

7 May 2011

New book explores the hidden world of viruses

"Carl Zimmer is one of the best science writers we have today. A Planet of Viruses is an important primer on the viruses living within and around all of us-sometimes funny, other times shocking, and always accessible. Whether discussing the common cold and flu, little-known viruses that attack bacteria or protect oceans, or the world's viral future as seen through our encounters with HIV or SARS, Zimmer's writing is lively, knowledgeable, and graced with poetic touches."-Rebecca Skloot, author of The Immortal Life of Henrietta Lacks.

7 May 2011

Latest research on HIV immunity can help develop vaccine

Latest insights into immunity to HIV could help to develop a vaccine to build antibodies' defences against the disease, a University of Melbourne, Australia study has found.

7 May 2011

Recent releases in Global Health

"In 25 countries across Asia, from Kazakhstan to Papua New Guinea, we work to support the success of emerging economies and help address the challenges of hunger and poverty. We do this not just by extending a helping hand, but sharing the hope of the American Dream to people around the world - the mother who eats less so her children can eat more, the girl who risks her life to get an education, the entrepreneur who beats the odds to create a small business that employs his neighbors," Rajiv Shah, USAID administrator, writes in a post on the agency's "Impact blog".

7 May 2011

AGA honors four young gastroenterologists with prestigious Research Scholar Awards

The American Gastroenterological Association Research Foundation has announced its 2011 research scholars. The grants have been awarded to four outstanding young gastroenterologists who promise to make significant strides in the field of gastrointestinal research.

6 May 2011

Ben-Gurion U. researcher receives Gates Foundation grant to develop fast, low-cost malaria device

Ben-Gurion University of the Negev researcher Alberto Bilenca, Ph.D., has been awarded a prestigious grant from the Bill & Melinda Gates Foundation to develop the a fast, low-cost device to accuracy diagnose malaria without the need for blood collection in field settings.

6 May 2011

Neutralizing antibodies generated by immunization associated with protection against SIV infection

Using a monkey model of AIDS, scientists have identified a vaccine-generated immune-system response that correlates with protection against infection by the monkey version of HIV, called simian immunodeficiency virus (SIV). The researchers found that neutralizing antibodies generated by immunization were associated with protection against SIV infection.

6 May 2011

Study examines community-based HIV testing programs in Africa, Southeast Asia

If you want to improve HIV testing rates in remote rural areas, get the community involved, says UCLA's Thomas Coates, who has directed a new study examining HIV testing programs in communities in Africa and Southeast Asia.

6 May 2011

Roundup: Vt. House vote on universal health care could come today; Calif. group warns of rising costs of retiree health care and pensions

The House is slated Thursday to take up a conference committee report on a bill designed to put the state on the path to universal health care by 2017 if not sooner. The bill sets up a new Green Mountain Care Board to design a system to provide health insurance to every Vermont resident.

6 May 2011

New test can diagnose deadly human fungal infections

Deadly human fungal infections caused by certain strains of Aspergillus fungi appear to be developing resistance to current drug treatments at an alarming rate, say scientists.

5 May 2011

NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign

Tulsa Shock guard Andrea Riley and Basketball Hall of Famer Bob Lanier teamed up with NBA Cares and the Society for Adolescent Health and Medicine today to bring Vaccines for Teens to the Tulsa community.

5 May 2011

Desmond Tutu calls on youth to lead next generation in HIV/AIDS fight

Nobel laureate Archbishop Desmond Tutu on Tuesday at a meeting on Robben Island, South Africa, that "was meant to be a symbolic passing of the torch from an older generation of activists to younger people," called on youth to lead the next generation in the fight against HIV/AIDS, Agence France-Presse reports.

5 May 2011

Study measures cost-effectiveness of trauma drug published in PLoS One

How much would you pay for an extra year of healthy life? The cost of filling up your car at the petrol pumps? Researchers at the London School of Hygiene & Tropical Medicine have found that a year of life could be saved for around the price of filling up the tank of an average family car in the UK - which is a fitting comparison bearing in mind that most of the patients who will benefit from this cheap life-saving drug have been hit by cars.

4 May 2011

New research sheds light on origins of cryptococcal fungal infection

New research has shed light on the origins of a fungal infection which is one of the major causes of death from AIDS-related illnesses. The study, published today in the journal PLoS Pathogens, funded by the Wellcome Trust and the BBSRC, shows how the more virulent forms of Cryptococcus neoformans evolved and spread out of Africa and into Asia.

4 May 2011

FTC, FDA take action on unproven STD drug products

The U.S. Food and Drug Administration and the Federal Trade Commission today announced a joint effort to remove products from the market that make unproven claims to treat, cure, and prevent sexually transmitted diseases.

4 May 2011

Immunetics receives NIH grant for new confirmatory test trial in Chagas' disease

Immunetics, Inc. today announced it has been awarded a $2.4 million, 3-year Phase II SBIR grant by the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, to support clinical trials of the company's new confirmatory test for Chagas' disease, a serious and potentially fatal parasitic infection.

4 May 2011

HIV/AIDS News and Research

Further Reading

Uganda: First vaccination for GMZ2 malaria vaccine trial

World's first urine-based tuberculosis diagnostics tool

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Study provides information about hematuria in microscopic urinalysis and urinary tract cancer

Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines

New book explores the hidden world of viruses

Latest research on HIV immunity can help develop vaccine

Recent releases in Global Health

AGA honors four young gastroenterologists with prestigious Research Scholar Awards

Ben-Gurion U. researcher receives Gates Foundation grant to develop fast, low-cost malaria device

Neutralizing antibodies generated by immunization associated with protection against SIV infection

Study examines community-based HIV testing programs in Africa, Southeast Asia

Roundup: Vt. House vote on universal health care could come today; Calif. group warns of rising costs of retiree health care and pensions

New test can diagnose deadly human fungal infections

NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign

Desmond Tutu calls on youth to lead next generation in HIV/AIDS fight

Study measures cost-effectiveness of trauma drug published in PLoS One

New research sheds light on origins of cryptococcal fungal infection

FTC, FDA take action on unproven STD drug products

Immunetics receives NIH grant for new confirmatory test trial in Chagas' disease

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News